Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Public Health ; 198: 238-244, 2021 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-34487867

RESUMO

OBJECTIVES: During the COVID-19 pandemic, ethnic minorities have been more susceptible to infection and demonstrated poorer outcomes. This study describes COVID-19 morbidity and mortality by ethnic group, represented by Arab and Jewish localities in Israel, during the different waves of the outbreak and addresses sociocultural aspects of the pandemic. STUDY DESIGN: A retrospective national archive study was conducted in Israel. METHODS: Data were obtained from the Ministry of Health's database, including daily information on Arab, Jewish or mixed localities, from February 2020 to February 2021. RESULTS: During the first wave of the pandemic, the incidence of COVID-19 in Arab compared with Jewish localities was 67% lower and mortality was 85% lower, in addition to lower rates of severe disease requiring hospitalisation. During the second and third waves, these trends reversed, with the proportion of positive tests, incidence and mortality in Arab localities reaching and then surpassing rates in Jewish localities. By September 2020, COVID-19 mortality was twice as high in Arab compared with Jewish localities. CONCLUSIONS: After low morbidity during the first wave of the COVID-19 pandemic, a surge in infections occurred in the Arab population during subsequent waves, to match and surpass the high incidence seen in the Jewish population. This unique pattern highlights the changing experiences of a minority group as the pandemic progressed and demonstrates how COVID-19 exacerbates existing disparities.


Assuntos
COVID-19 , Pandemias , Árabes , Humanos , Israel/epidemiologia , Judeus , Grupos Minoritários , Morbidade , Estudos Retrospectivos , SARS-CoV-2
2.
Cancer Genet Cytogenet ; 149(2): 154-60, 2004 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15036891

RESUMO

Xeroderma pigmentosum (XP) is a rare autosomal recessive syndrome. Laboratory investigations have failed to detect any consistent anomaly in cells from XP heterozygotic subjects, although examples of behavior intermediate between normal and XP cells have been reported. To estimate random aneuploidy we applied fluorescence in situ hybridization (FISH) with alpha-satellite probes for chromosomes 8 and 9 and replication pattern for TP53 (p53), ERBB2 (HER-2/neu), and MYCN (N-MYC) loci and for the imprinted SNRPN locus. A significantly higher rate of aneuploidy rate was observed in XP patients and carriers than in controls. The asynchrony pattern was significantly higher in XP carriers and patients with all three coding loci analyzed and significantly lower in XP patients and carriers with the imprinted locus SNRPN than in the control group. Molecular cytogenetic parameters such as random aneuploidy and replication pattern, which are known to reflect chromosomal instability, may be part of the tumorigenesis process. In XP patients and carriers, this genetic instability may represent a potential for developing malignancies.


Assuntos
Heterozigoto , Xeroderma Pigmentoso/genética , Aneuploidia , Autoantígenos , Análise Citogenética , Fibroblastos , Impressão Genômica , Humanos , Ribonucleoproteínas Nucleares Pequenas/genética , Proteínas Centrais de snRNP
4.
Vet Res ; 25(2-3): 322-6, 1994.
Artigo em Inglês | MEDLINE | ID: mdl-8038808

RESUMO

A prevention programme for caprine viral arthritis-encephalitis was monitored in 363 goat herds between 1988 and 1990. The level of contamination in the female kids fell from 49.5 to 25% by the end of the 2-yr period during which the programme was applied. Some 19% of the female kids that had been substitute colostrum (cow colostrum or goat colostrum heated to 56 degrees C for 1 h) were contaminated compared with 45% of those that had been given raw colostrum. The segregation between the animals submitted to prevention measures and those that were not are presented to illustrate the efficiency of prevention of horizontal transmission.


Assuntos
Vírus da Artrite-Encefalite Caprina , Doenças das Cabras/prevenção & controle , Infecções por Lentivirus/veterinária , Animais , Anticorpos Antivirais/sangue , Vírus da Artrite-Encefalite Caprina/imunologia , Colostro/microbiologia , Feminino , Cabras , Infecções por Lentivirus/prevenção & controle
5.
J Comput Assist Tomogr ; 9(5): 889-93, 1985.
Artigo em Inglês | MEDLINE | ID: mdl-2993382

RESUMO

The CT appearances of 18 clinically proven cases of abdominal neuroblastoma were reviewed retrospectively with the aim of characterizing those features that best distinguish them from Wilms tumors. The study found that the most common characteristics of neuroblastoma on CT are usually a suprarenal mass displacing the kidney and either growing down into the hilum or actually infiltrating the kidney; extension of the tumor across the midline to displace the major vessels; presence of calcification in the tumor.


Assuntos
Neoplasias Abdominais/diagnóstico por imagem , Neoplasias Renais/diagnóstico por imagem , Neuroblastoma/diagnóstico por imagem , Tomografia Computadorizada por Raios X , Tumor de Wilms/diagnóstico por imagem , Criança , Pré-Escolar , Diagnóstico Diferencial , Feminino , Humanos , Lactente , Masculino
6.
Oral Surg Oral Med Oral Pathol ; 46(2): 283-95, 1978 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-101927

RESUMO

A preliminary in vivo and in vitro electron microscopic study of root canals treated endodontically with EDTA-C and Salvizol proved the latter to be superior as a chemomechanical and irrigation solution, especially in the apical third of the roots. A further virtue of Salvizol, as has been demonstrated, is its capability to dissolve the organic matrix of dentin, thus exposing the mineralizing front and the patent tubules even in the apical third of the canal. The combined properties of Salvizol which introduce it as a chemotherapeutic agent for endodontics are: (1) broad spectrum of bactericidal activity, (2) ability to dissolve calcium, (3) neutral pH, (4) cleansing potency, and (5) biologic compatibility.


Assuntos
Dequalínio/farmacologia , Compostos de Quinolínio/farmacologia , Tratamento do Canal Radicular , Cavidade Pulpar/efeitos dos fármacos , Cavidade Pulpar/ultraestrutura , Dentina/ultraestrutura , Dequalínio/análogos & derivados , Ácido Edético/farmacologia , Humanos , Microscopia Eletrônica , Pulpectomia , Irrigação Terapêutica
7.
Aust N Z J Med ; 17(3): 279-82, 1987 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-2823761

RESUMO

Sixty-five patients with small cell lung cancer were treated with VP16, vincristine, cyclophosphamide, and doxorubicin (VOCA) intravenously at three-week intervals. Patients with limited disease received four cycles with responders receiving radiation to the primary site and prophylactic cranial irradiation. Patients with extensive disease received chemotherapy only. Of 59 patients evaluable for chemotherapy response, eight (14%) achieved complete remission and 30 (51%) partial remission. Major side-effects included myelosuppression, alopecia, nausea, and vomiting. Reinduction with VOCA at relapse yielded objective or subjective response in four of seven patients. This regimen is active in small cell lung cancer and was well tolerated by patients. Reinduction of response was possible in a small number of patients retreated and may provide useful palliation for those who relapse when treatment is discontinued.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Carcinoma de Células Pequenas/tratamento farmacológico , Neoplasias Pulmonares/tratamento farmacológico , Adulto , Idoso , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Carcinoma de Células Pequenas/radioterapia , Terapia Combinada , Ciclofosfamida/administração & dosagem , Ciclofosfamida/efeitos adversos , Doxorrubicina/administração & dosagem , Doxorrubicina/efeitos adversos , Feminino , Humanos , Neoplasias Pulmonares/radioterapia , Masculino , Pessoa de Meia-Idade , Podofilotoxina/administração & dosagem , Podofilotoxina/efeitos adversos , Vincristina/administração & dosagem , Vincristina/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA